uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Ozespa
Application withdrawn
Human
Details
EMA number
EMEA/H/C/002019
ATC code
L04AC09
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Not specified
MeSH:
Psoriasis
Group:
Immunosuppressants
Active substances
briakinumab
Marketing Authorisation Holder
Abbott Laboratories Ltd.
MAH
Ozespa | uMedical